Simplified Bone Marrow Cryopreservation Using Dimethyl Sulfoxide and Hydroxyethyl Starch as Cryoprotectants

2020 ◽  
pp. 341-349
Author(s):  
Patrick J. Stiff
Vox Sanguinis ◽  
1985 ◽  
Vol 48 (2) ◽  
pp. 89-104 ◽  
Author(s):  
Phyllis I. Warkentin ◽  
Joanne M. Hilden ◽  
John H. Kersey ◽  
Norma K.C. Ramsay ◽  
Jeffrey McCullough

PLoS ONE ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. e88696 ◽  
Author(s):  
Keitaro Imaizumi ◽  
Naoki Nishishita ◽  
Marie Muramatsu ◽  
Takako Yamamoto ◽  
Chiemi Takenaka ◽  
...  

Blood ◽  
1987 ◽  
Vol 70 (4) ◽  
pp. 974-978 ◽  
Author(s):  
PJ Stiff ◽  
AR Koester ◽  
MK Weidner ◽  
K Dvorak ◽  
RI Fisher

To develop a simplified method of bone marrow (BM) cryopreservation, changes were made in the standard method in three areas: the cryoprotectant, the method of cell freezing, and the storage temperature. Unfractionated BM cells from 60 patients were cryopreserved in 300-mL aliquots in both dimethylsulfoxide (DMSO) and hydroxyethyl starch (HES), a combination known to preserve granulocytes successfully. The cells were frozen without rate-controlled freezing by simple immersion into a -80 degrees C freezer where they remained until the time of reinfusion. The 60 patients underwent 72 autologous transplants after three high-dose chemotherapy regimens: 30 received high-dose carmustine in combination, five received high-dose busulfan and cyclophosphamide, and 37 received high-dose aziridinylbenzoquinone. The BM was infused for more than 30 minutes after rapid thawing at 37 degrees C. The mean post-thaw nucleated cell recovery was 96% +/- 11.6%, and Trypan blue dye exclusion was 82.2% +/- 9.2%. The mean postthaw CFU-GM and BFU-E recoveries were 81.9% +/- 39.0% and 90.5% +/- 41.2%. Complete count recovery occurred in 68 of 72 transplants. Median times to a WBC count greater than 1,000/microL, a granulocyte count greater than 1,000/microL and a platelet count greater than 20,000/microL were 15, 21, and 15 days, respectively. Risk factors for delayed recovery were not found. Unfractionated BM cells can be successfully cryopreserved in the DMSO/HES mixture rapidly and inexpensively, without rate-controlled freezing or storage at liquid nitrogen temperatures.


Blood ◽  
1987 ◽  
Vol 70 (4) ◽  
pp. 974-978 ◽  
Author(s):  
PJ Stiff ◽  
AR Koester ◽  
MK Weidner ◽  
K Dvorak ◽  
RI Fisher

Abstract To develop a simplified method of bone marrow (BM) cryopreservation, changes were made in the standard method in three areas: the cryoprotectant, the method of cell freezing, and the storage temperature. Unfractionated BM cells from 60 patients were cryopreserved in 300-mL aliquots in both dimethylsulfoxide (DMSO) and hydroxyethyl starch (HES), a combination known to preserve granulocytes successfully. The cells were frozen without rate-controlled freezing by simple immersion into a -80 degrees C freezer where they remained until the time of reinfusion. The 60 patients underwent 72 autologous transplants after three high-dose chemotherapy regimens: 30 received high-dose carmustine in combination, five received high-dose busulfan and cyclophosphamide, and 37 received high-dose aziridinylbenzoquinone. The BM was infused for more than 30 minutes after rapid thawing at 37 degrees C. The mean post-thaw nucleated cell recovery was 96% +/- 11.6%, and Trypan blue dye exclusion was 82.2% +/- 9.2%. The mean postthaw CFU-GM and BFU-E recoveries were 81.9% +/- 39.0% and 90.5% +/- 41.2%. Complete count recovery occurred in 68 of 72 transplants. Median times to a WBC count greater than 1,000/microL, a granulocyte count greater than 1,000/microL and a platelet count greater than 20,000/microL were 15, 21, and 15 days, respectively. Risk factors for delayed recovery were not found. Unfractionated BM cells can be successfully cryopreserved in the DMSO/HES mixture rapidly and inexpensively, without rate-controlled freezing or storage at liquid nitrogen temperatures.


Blood ◽  
1969 ◽  
Vol 33 (6) ◽  
pp. 918-923 ◽  
Author(s):  
R. STORB ◽  
R. B. EPSTEIN ◽  
R. F. LE BLOND ◽  
R. H. RUDOLPH ◽  
E. D. THOMAS

Abstract Prompt initial bone marrow engraftment was observed in 10 lethally irradiated dogs receiving infusions of 9.8 to 30.0 x 109 allogeneic marrow cells stored at -80 C. in dimethyl sulfoxide. The 3 recipients of bone marrow from unrelated donors, mismatched by canine histocompatibility testing, subsequently rejected their grafts and died within 16 days with marrow hypoplasia. The 3 dogs with matched unrelated donors and the 4 with matched litter mate donors all showed sustained marrow engraftment. Evidence of marrow repopulation by allogeneic cells was obtained by cytogenetic studies in one and by change to donor red cell type in 3 instances.


2015 ◽  
Vol 52 (1) ◽  
pp. 94-98
Author(s):  
Margriet J. Dijkstra-Tiekstra ◽  
Airies C. Setroikromo ◽  
Marcha Kraan ◽  
Effimia Gkoumassi ◽  
Janny de Wildt-Eggen

Sign in / Sign up

Export Citation Format

Share Document